March 2, 2017.
Will AIDS have its vaccine? Nothing is less certain and, in Marseille, where a promising clinical trial announced the creation of a treatment soon, the CNRS and the Biosantech laboratory seem to have gone to war.
A CNRS researcher promised good results in the search for an AIDS vaccine
In Marseille, medical research is progressing and researchers are said to be very close to the first vaccine against AIDS. This discovery, long awaited by the medical community, may never succeed.. At issue, a strange affair between the CNRS, where the researcher behind the creation of this treatment comes from, and the Biosantech laboratory, which hosts the clinical trial aimed at proving the effectiveness of the vaccine.
It was when Erwann Loret, a researcher at the CNRS, was about to begin phase IIb of his clinical study that relations with the state body seemed to have deteriorated and, for an unknown reason, the latter did not receive authorization from his superiors to continue the project. ” The CNRS told him that he had to stop his research and stop all communications about them. “, Confirmed Corinne Treger, president of Biosantech, for the daily 20 minutes.
Will the Biosantech laboratory continue the clinical trial?
Opposite, the CNRS seems to be playing the innocence card and told Why Doctor ” not be aware of any clinical trial continuation project “. ” To date, the company Biosantech holds a patent license authorizing it to use the technology. There is no longer any formalized co-development relationship between the CNRS and this company “, Added the organization.
Difficult to identify the true from the false in this story, one thing is certain, in Marseille, the clinical trial of Professor Loret is pending. However, some say thatthis could be the umpteenth announcement effect of the Biosantech laboratory, customary, and that the clinical trial may well continue, despite these threats.
Read also: More and more sexually transmitted infections in France
Sybille Latour
